3van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis [ J ]. Osteoporos Int, 2002,13 (10) : 777-787. 被引量：1
4Schott AM, Hans D, Sornay-Rendu E, et al. Ultrasound measurements on oscalcis: precision and age related changes in a normal female population[J]. Osteoporosis Int, 1993,3 ( 5 ): 249- 254. 被引量：1
6Moroni A, Faldini C, Hoang-Kim A, et al. Alendronate improves screw fixation in osteoporotic bone [J]. J Bone Joint Surg(Am), 2007,89( 1 ) :96-101. 被引量：1
7Black D M, Thompson D E, Bauer D C, et al. Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial [J]. J Clin Endocrinol Metab,2000,85 (11) : 4118-4124. 被引量：1
8Goh S K, Yang K Y, Koh J S, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution [J]. J Bone Joint Surg(Br), 2007,89 (3) : 349-353. 被引量：1
9Neviaser A S, Lane J M, Lenart B A, et al. Low-Energy Femoral Shaft Fractures Associated With Alendronate Use [J]. J Orthop Trauma, 2008,22 (5) : 346-350. 被引量：1
10Bone H G, Hosking D, Devogelaer j P, et al. Ten years' experience with alendronate for osteoporosis in postmenopausal women [J]. N Engl J Med, 2004,350(12) : 1189-1199. 被引量：1
